The latest price target for GE HealthCare Techs (NASDAQ:GEHC) was reported by Wells Fargo on October 31, 2024. The analyst firm set a price target for $96.00 expecting GEHC to rise to within 12 months (a possible 17.19% upside). 21 analyst firms have reported ratings in the last year.

The latest analyst rating for GE HealthCare Techs (NASDAQ:GEHC) was provided by Wells Fargo, and GE HealthCare Techs maintained their overweight rating.

The last upgrade for GE HealthCare Technologies Inc happened on September 18, 2024 when BTIG raised their price target to $100. BTIG previously had a neutral for GE HealthCare Technologies Inc.

The last downgrade for GE HealthCare Technologies Inc happened on September 26, 2024 when UBS changed their price target from $84 to $74 for GE HealthCare Technologies Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE HealthCare Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE HealthCare Techs was filed on October 31, 2024 so you should expect the next rating to be made available sometime around October 31, 2025.

While ratings are subjective and will change, the latest GE HealthCare Techs (GEHC) rating was a maintained with a price target of $95.00 to $96.00. The current price GE HealthCare Techs (GEHC) is trading at is $81.92, which is out of the analyst’s predicted range.